U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225283) titled 'Developing Resiliency and Exercise Using AI-based Messaging' on Nov. 04.
Brief Summary: This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus Type 2
Intervention:
BEHAVIORAL: DREAM
Participants will engage in twice weekly messaging sessions and will work towards a physical activity goal each week for a total of eight weeks.
Recruitment Status: NOT_Y...